Clinical trial
Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients…
NCT00232011 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00232011 |
|---|---|
| Title | Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis |
| Official title | A Clinical Study Continued From the Confirmatory Study to Assess the Efficacy and Safety of ASM981 Cream in Adult Atopic Dermatitis Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus Cream 1% |
| Enrollment | 160 |
| Start date | May 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: